The authors concluded that systemic furin inhibition reduces vascular remodeling and atherosclerosis, potentially through the modulation of MMP2 activity, offering atheroprotective benefits in hyperlipidemic Ldlr−/− mice [70]. This evidence concerns the gene FURIN and atherosclerosis.